These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38414976)

  • 1. Enhanced Donor Antigen Presentation by B Cells Predicts Acute Cellular Rejection and Late Outcomes After Transplantation.
    Ashokkumar C; Ningappa M; Raghu V; Mazariegos G; Higgs BW; Morgan P; Remaley L; Fazzolare Martin T; Holzer P; Trostle K; Xu Q; Zeevi A; Squires J; Soltys K; Horslen S; Khanna A; Ganoza A; Sindhi R
    Transplant Direct; 2024 Mar; 10(3):e1589. PubMed ID: 38414976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of peripheral CD154
    Boix F; Legaz I; Minhas A; Alfaro R; Jiménez-Coll V; Mrowiec A; Martínez-Banaclocha H; Galián JA; Botella C; Moya-Quiles MR; Sanchez-Bueno F; Robles R; de la Peña-Moral J; Ramirez P; Pons JA; Minguela A; Muro M
    Clin Exp Immunol; 2021 Feb; 203(2):315-328. PubMed ID: 33025622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of low pre-transplant donor specific antibodies (DSA) in living donor kidney recipients with negative complement-dependent cytotoxicity crossmatches (CDCXM), and negative flow cytometry crossmatches (FLXM) - A single-center experience.
    Olszowska-Zaremba N; Gozdowska J; Zagożdżon R
    Transpl Immunol; 2022 Oct; 74():101672. PubMed ID: 35868613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graft immunologic events in deceased donor kidney transplant recipients with preformed HLA-donor specific antibodies.
    Ixtlapale-Carmona X; Arvizu A; De-Santiago A; González-Tableros N; López M; Castelán N; Marino LA; Uribe-Uribe NO; Contreras AG; Vilatobá M; Morales-Buenrostro LE; Alberú J
    Transpl Immunol; 2018 Feb; 46():8-13. PubMed ID: 28974434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretransplant angiotensin II type 1-receptor antibodies are a risk factor for earlier detection of de novo HLA donor-specific antibodies.
    Cuevas E; Arreola-Guerra JM; Hernández-Méndez EA; Salcedo I; Castelán N; Uribe-Uribe NO; Vilatobá M; Contreras-Saldívar AG; Sánchez-Cedillo AI; Ramírez JB; de Rungs D; Granados J; Morales-Buenrostro LE; Alberú J
    Nephrol Dial Transplant; 2016 Oct; 31(10):1738-45. PubMed ID: 27220757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Low-Level Donor-Specific Anti-HLA Antibody on Posttransplant Clinical Outcomes in Kidney Transplant Recipients.
    Lee H; Lee H; Eum SH; Ko EJ; Min JW; Oh EJ; Yang CW; Chung BH
    Ann Lab Med; 2023 Jul; 43(4):364-374. PubMed ID: 36843405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of pretransplant suspected HLA antibody on the long-term outcome of the graft kidney: A retrospective cohort study.
    Yang BQ; Bai YJ; Wang LL; Dai B; Li YM; Tao Y; Shi YY
    Transpl Immunol; 2024 Feb; 82():101922. PubMed ID: 37657691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Class II Human Leukocyte Antigen Epitope Mismatch Predicts De Novo Donor-Specific Antibody Formation After Liver Transplantation.
    Kubal CA; Mangus R; Ekser B; Mihaylov P; Ceballos B; Higgins N; Chalasani N; Ghabril M; Nephew L; Lobashevsky A
    Liver Transpl; 2018 Aug; 24(8):1101-1108. PubMed ID: 30142248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Kidney Graft Loss With De Novo Produced Donor-Specific and Non-Donor-Specific HLA Antibodies Detected by Single Antigen Testing.
    Süsal C; Wettstein D; Döhler B; Morath C; Ruhenstroth A; Scherer S; Tran TH; Gombos P; Schemmer P; Wagner E; Fehr T; Živčić-Ćosić S; Balen S; Weimer R; Slavcev A; Bösmüller C; Norman DJ; Zeier M; Opelz G;
    Transplantation; 2015 Sep; 99(9):1976-80. PubMed ID: 25769065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
    Kannabhiran D; Lee J; Schwartz JE; Friedlander R; Aull M; Muthukumar T; Campbell S; Epstein D; Seshan SV; Kapur S; Sharma VK; Suthanthiran M; Dadhania D
    Transplantation; 2015 Jun; 99(6):1156-64. PubMed ID: 25629531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced B Cell Alloantigen Presentation and Its Epigenetic Dysregulation in Liver Transplant Rejection.
    Ningappa M; Ashokkumar C; Higgs BW; Sun Q; Jaffe R; Mazariegos G; Li D; Weeks DE; Subramaniam S; Ferrell R; Hakonarson H; Sindhi R
    Am J Transplant; 2016 Feb; 16(2):497-508. PubMed ID: 26663361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative Frequencies of Alloantigen-Specific Helper CD4 T Cells and B Cells Determine Mode of Antibody-Mediated Allograft Rejection.
    Alsughayyir J; Chhabra M; Qureshi MS; Mallik M; Ali JM; Gamper I; Moseley EL; Peacock S; Kosmoliaptsis V; Goddard MJ; Linterman MA; Motallebzadeh R; Pettigrew GJ
    Front Immunol; 2018; 9():3039. PubMed ID: 30740108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor/Recipient HLA Molecular Mismatch Scores Predict Primary Humoral and Cellular Alloimmunity in Kidney Transplantation.
    Meneghini M; Crespo E; Niemann M; Torija A; Lloberas N; Pernin V; Fontova P; Melilli E; Favà A; Montero N; Manonelles A; Cruzado JM; Palou E; Martorell J; Grinyó JM; Bestard O
    Front Immunol; 2020; 11():623276. PubMed ID: 33776988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allospecific CD154+ T cells identify rejection-prone recipients after pediatric small-bowel transplantation.
    Ashokkumar C; Gupta A; Sun Q; Ningappa MB; Higgs BW; Mazariegos G; Fazzolare T; Remaley L; Soltys K; Bond G; Abu-Elmagd K; Sindhi R
    Surgery; 2009 Aug; 146(2):166-73. PubMed ID: 19628070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Living-Donor Kidney Transplant With Preformed Donor-Specific Antibodies.
    Itabashi Y; Aikawa A; Muramatsu M; Hyoudou Y; Shinoda K; Takahashi Y; Sakurabayashi K; Mizutani T; Oguchi H; Arai T; Kawamura T; Hamasaki Y; Sakai K; Shishido S
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):43-49. PubMed ID: 30777522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated myeloid: plasmacytoid dendritic cell ratio associates with early acute cellular rejection in pediatric small bowel transplantation.
    Gupta A; Ashokkumar C; Ningappa M; Sun Q; Higgs BW; Snyder S; Johnson M; Zeevi A; Abu-Elmagd KM; Thomson AW; Mazariegos GV; Sindhi R
    Transplantation; 2010 Jan; 89(1):55-60. PubMed ID: 20061919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deceased donor kidney transplantation across donor-specific antibody barriers: predictors of antibody-mediated rejection.
    Schwaiger E; Eskandary F; Kozakowski N; Bond G; Kikić Ž; Yoo D; Rasoul-Rockenschaub S; Oberbauer R; Böhmig GA
    Nephrol Dial Transplant; 2016 Aug; 31(8):1342-51. PubMed ID: 27190362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and Clinical Impact of Donor-Specific Alloantibody Among Intestinal Transplant Recipients.
    Cheng EY; Everly MJ; Kaneku H; Banuelos N; Wozniak LJ; Venick RS; Marcus EA; McDiarmid SV; Busuttil RW; Terasaki PI; Farmer DG
    Transplantation; 2017 Apr; 101(4):873-882. PubMed ID: 27490417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DQ Mismatching and Kidney Transplant Outcomes.
    Leeaphorn N; Pena JRA; Thamcharoen N; Khankin EV; Pavlakis M; Cardarelli F
    Clin J Am Soc Nephrol; 2018 May; 13(5):763-771. PubMed ID: 29685925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting Cellular Rejection With a Cell-Based Assay: Preclinical Evaluation in Children.
    Ashokkumar C; Soltys K; Mazariegos G; Bond G; Higgs BW; Ningappa M; Sun Q; Brown A; White J; Levy S; Fazzolare T; Remaley L; Dirling K; Harris P; Hartle T; Kachmar P; Nicely M; OʼToole L; Boehm B; Jativa N; Stanley P; Jaffe R; Ranganathan S; Zeevi A; Sindhi R
    Transplantation; 2017 Jan; 101(1):131-140. PubMed ID: 26950712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.